chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hot to the touch; initially had swelling on arm/ area where I received the vaccine is swollen again; Initially she had some swelling on her and redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE SWELLING (initially had swelling on arm/ area where I received the vaccine is swollen again) and VACCINATION SITE ERYTHEMA (Initially she had some swelling on her and redness) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), HYDROCHLOROTHIAZIDE, METFORMIN, LOSARTAN, PROGESTERONE and LIOTHYRONINE.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE SWELLING (initially had swelling on arm/ area where I received the vaccine is swollen again) and VACCINATION SITE ERYTHEMA (Initially she had some swelling on her and redness). On 26-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch). At the time of the report, VACCINATION SITE WARMTH (hot to the touch) outcome was unknown and VACCINATION SITE SWELLING (initially had swelling on arm/ area where I received the vaccine is swollen again) and VACCINATION SITE ERYTHEMA (Initially she had some swelling on her and redness) had resolved with sequelae.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Patient also states she is taking an inhaler and a birth control pill, however medication name was not specified.  Patient also reported she received an allergy shot in the same arm on Thursday, 21JAN2021, but not in the same area as the vaccine.
Patient came to my pharmacy approximately 4 months after the initial date. The injection area was severely infected. He said that soon after there was a lump that never went away. The weekend prior to having seen me he said it "ruptured" and pustules formed on the surface. I recommended a trip to the doctor, expressing the pus out, and antibiotic ointment and alcohol in the meantime.
L distal internal jugular venous thrombus found on 6/29 after pt had three days of squeezing sensation on upper arm followed by acute pain on day of presentation to ED. In ED upper extremity Doppler demonstrated clot. Pt transferred to our hospital where she started on anticoagulation therapy for treatment.
This spontaneous report as received from an unspecified person who found a study refers to an unspecified number of female (girls) patients of unknown age. On an unknown date, the patients were vaccinated with a dose of GARDASIL (dose, frequency, lot# and expiration date were not reported) for prophylaxis. On an unknown date (reported as since 2016), the patients experienced long term absent periods. The outcome of the event was not reported. The relatedness between vaccination with GARDASIL and the event was not reported. This is one of several reports from the same source. Additional information is not expected. Sender's Comments: US-009507513-1702USA004704: IE-009507513-1508IRL006083: GB-009507513-1604GBR014439: GB-009507513-1702BGR004046.
hurt; This case was reported by a consumer and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The patient got vaccinated against shingles and it hurted for few days. The patient felt protected and felt good.
brought to hospital via EMS with c/o weakness x 2 wks; O2 sats 88% on RA; placed on O2; pt's O2 requirements increased during hospitalization, NC, NRB, Vapotherm; ICU; pt required intubation and coded; vasopressors given; pt developed several arrhythmias during his stay, type 2 block as well as a questionable complete heart block; pt went into asystole; CPR performed but pt passed away in the hospital
Initial report received on 19 November 2009 from a consumer. A 43 year old female patient received H1N1 (lot number not provided) intramuscularly in the left deltoid on 07 November 2009. On 10 November 2009, three days post vaccination, the patient reported periods of intermittent muscle pain in the left shoulder and arm and weakened left hand strength. There was no swelling or redness present. The patient stated that the symptoms were getting worse. The patient was not recovered at the time of the report. List of Documents held by Sender: none.
Pt poss bitten by a mouse on the hand; MD advised Td booster; evening of day pt vaxed the arm @ site of inject had hardened lump; c/o discomfort to areabut able to rasie arm w/effort;
Information has been received from a registered nurse concerning a 4 year old Caucasian male who on 3/16/96 was vaccinated SC with one dose of varicella virus vaccine live. There was no concomitant medication. On 1/1/00 the patient experienced a rash with erythematous vesicles, macules, and vesicles. On 1/2/00 he experienced new lesions on the face and under the extremities with 1-2 open vesicles. The rash was also on the trunk. There was no fever. The patient was not exposed to wild type varicella. No further information is available.
Patient was taken to the ER and diagnosed with febrile seizure. We are not sure whether or not the seizure is related to the vaccines.
This spontaneous report as received from a pharmacist refers concerning a 75 years old female patient who on 24-AUG-2012 was vaccinated with a dose of ZOSTAVAX (Lot# 672675/0068AE) (subcutaneous, dose not reported). Concomitant medications included VALTREX, PROZAC, PLAVIX, potassium, PRAVACHOL, digoxin, "DEMEDEX", "AEROCEPT" and "BACTROVON". On 27-AUG-2012 the patient experienced rash which occurred in 72 hours on an unknown portion of the body after receiving the medication. The patient was not given any information of the location of the rash. At the time of reporting, the outcome of rash was unknown. Additional information has been requested.
On 02/22/2021 I had 2 minutes of heart pain. I told my husband if I fell down to call 911 and tell them I was having a heart attack. But it passed. On 03/09/2021 I had an appointment with a cardiologist. When I went in, they did an EKG and it was abnormal. I told her about the heart pain I had 2 weeks ago. That was concerning for her. I described her my family history which is very prominent for heart diseases. I have a completely normal BMI and I take good care of myself. My EKG had Inverted P waves which indicates ischemia. She sent me to the hospital and I was admitted. I stayed for a night. They did several tests and everything came back normal. They did not know why I had that heart pain. They did a cardiac CT and they saw all my vessels were normal except LED it was a 1. At the end they let me go home. I had another EKG  about a month later and the P waves are still inverted which still indicates ischemia.
Patient had a major site reaction following injection, affeting large part of the arm; This spontaneous report aws received from a reporter of unknown credentials and refers to a 48-year-old female patient. No information on patient's medical history, current conditions and concomitant medications was provided.  On an unknown date the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) for prophylaxis (exact dose, dose number, route and site of administration, lot number and expiration date were not provided).  On an unknown date the patient experienced vaccination site reaction. The patient said she is highly susceptible to such reactions, as well as various illnesses. The outcome of vaccination site reaction was unknown. Action taken with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) regarding the events was not applicable.   The reporter considered vaccination site reaction to be related to Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23).
On May 8th, I was at my grandchild's football game. I was outside for over 3 hours. It was a very windy day, and I had a lot of coffee. In the evening, I went to my grandchild's concert at school at 7:00PM. While at the concert, my neck started throbbing and I started getting a headache. When the concert ended, I started having trouble walking back to the vehicle. I wasn't able to get out of the truck or walk myself to the door, so my son had to help me. When I got home, I took some Excedrin or Tylenol, but after a bit, I ended up throwing up. I was in my bed and I was so dizzy that I couldn't get up, so I threw up on my feet and the floor. The next morning, I woke up and felt like I had the flu. I threw up several times over the weekend. Come Monday, 05/10/2021, I asked my son if he could pick up some Pepto bismol because it helped a bit. On Monday evening, my son bought me a humidifier because we thought that maybe it was a sinus infection. On Wednesday, 05/12, I had to take an Uber to the hospital. While I was at the hospital, I had an MRI, a CT scan and blood work drawn. At first, they thought there was a blood clot in my lungs, but then it was ruled out. They gave me Benadryl and something else (he called it a cocktail). It took away some of the pain, but the headache never went away. They kept me overnight for observation and to do a second MRI in the morning. I was on a heart monitor the whole time. I saw a doctor before I left, and they weren't able to locate any problems. They came up with migraines. I was given a shot of sumatriptan and the same medicine in pill form 100mg to take when I was at home. As of today, 3 months after receiving my vaccine, I am still feeling foggy, and I have had quite a few headaches. I ended up seeing a Neurologist. With the medicine she gave me, I have not been feeling like myself at all. I stopped taking the medicine on 07/08/2021.
(I think this links back to having endometriosis.  I am not currently having my period but am experiencing the same symptoms as if I were.) Intense pain in pelvic area (same pain as during period) -- starting a day after vaccine and still ongoing, four days later Intense nausea (unable to move)--mostly two days after shot Unending headache--starting a day after vaccine and still ongoing Some bloating Some heartburn
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 36-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 24-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant were reported.  No treatment were reported.
Site: Pain at Injection Site-Medium, Additional Details: Patient is having shoulder pain. Had the normal soreness the first few days but pain started happening with shoulder movement after a few days. Has not seen the doctor. I advised them to call. On their way out of town and planning on calling doctor when they arrive.
A few days following the vaccination I developed the worse migraine I have ever had, plus double vision.  Also I had brain fog, dizziness and I lost some vision in my right eye.  On the third day I went to the ER where I was tested for stroke or brain tumor (both negative).  I saw a neurologist four days later.  Nine days later I continue to have double vision, a bad headache and vision loss in my right eye.
Covid 19 virus and tested positive; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (COMIRNATY), administration date 08Jan2022 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (non-serious) with onset 15Jan2022, outcome "unknown", described as "Covid 19 virus and tested positive". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient had first dose of the Pfizer COVID 19 vaccine on 08Jan2022. Last Saturday they contracted Covid 19 virus and tested positive. He described it as horrible, terrible, very ill, chills, headache, and more symptoms of the Covid 19 virus.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200112254 same reporter/product/event, different patient
pt recvd vax; devel fever & local rxn of soreness, swelling & rash at the inject site;
child fainted and hit head on  table a minute after vaccine was  given and then his eyes rolled  back and forth and his jaw  started opening/closing.
weak; lethargic; At injection site there is pink ring 3-4 inch in diameter; appetite has decreased; Arm was stiff; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Arm was stiff), ASTHENIA (weak), LETHARGY (lethargic), VACCINATION SITE REACTION (At injection site there is pink ring 3-4 inch in diameter) and DECREASED APPETITE (appetite has decreased) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergy to Sulfa drug).    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Arm was stiff). On 05-Mar-2021, the patient experienced ASTHENIA (weak), LETHARGY (lethargic), VACCINATION SITE REACTION (At injection site there is pink ring 3-4 inch in diameter) and DECREASED APPETITE (appetite has decreased). At the time of the report, MUSCULOSKELETAL STIFFNESS (Arm was stiff), ASTHENIA (weak), LETHARGY (lethargic), VACCINATION SITE REACTION (At injection site there is pink ring 3-4 inch in diameter) and DECREASED APPETITE (appetite has decreased) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Concomitant medications were provided No Treatment information provided    Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: No specific follow-up information recorded.
Information has been received from a physician concerning a 16 year old female who on 01-JUL-2009 was vaccinated with the first dose of GARDASIL (lot #, dose and route not reported) along with Td, MENACTRA and a second dose of VARIVAX. The physician reported that the female patient was seen for seizure activity which developed at an unspecified date after her second dose of GARDASIL on 19-MAR-2010 along with an unidentified manufacturer's brand of influenza vaccine (manufacturer unknown). She had not received the third dose of GARDASIL. On 01-NOV-2010, this female patient had an electroencephalogram for "seizure activity" but the doctors could not find "an answer". No treatment was given for the event. At some time after this test, the child's mother called physician because she thought the seizure activity might be caused by the GARDASIL. At the time of the report, the patient had not recovered. Upon internal review, seizure activity was determined to be an other important medical event. Additional information has been requested.
Pt received yellow fever and flu vaccines and 30 minutes later, developed urticaria and shortness of breath, prompting evaluation and treatment at MD's office. Received Epinephrine and Benadryl IM X1 and IVF (NSS X 1L).
Developed shingles on forehead - red rash with discharge 1-2 wks post vaccine, VALTREX ordered
Patient currently hospitalized (9) days. HOSPITAL COURSE: Patient is a 58-year-old female with a history of primary progressive MS who presented with increasing generalized weakness, worse from her baseline (at baseline, right lower extremity worse than left lower extremity) and dyspnea/cough.  In ER she was noted to have COVID-19 along with chest x-ray showing patchy bilateral airspace disease. She has received her COVID vaccination and her booster in October. She was admitted and started on decadron. She was seen by neurology who recommended MRI brain to rule out acute demyelinating lesions. MRI brain without acute changes compared to prior. Neurology felt weakness represented a pseudo flare in the setting of acute COVID infection.  Oxygen needs began to increase. CT angio thorax showing no PE. The patient was transitioned to IV solumedrol, started on IV lasix and ppx antibiotics for CAP.    The patient slowly started to show improvement and oxygen was weaned down to 2L at and rest and 4L with activity. Pulm rehab evaluated the patient for home oxygen.   PT/OT evaluated the patient and recommended IRC, but did not get insurance authorization and SAR was recommended instead. After further discussion with the patient she is declining SAR and prefers to discharge home. She will be sent home with a prednisone taper and HHC will be arranged.
Pt. had signs of  anaphylaxis within 5 minutes of injection (lip and eye swelling, rash, dizziness, nausea)  Given epi pen and transported to the ED where she was treated with steroids and antihistamines.  she was observed for several hours then sent home.  No permanent sequalae, will not receive a second dose.
Patients first dose received April 13, 2021, 2nd dose received June 3, 2021.
Patient received vaccine past 12 hours expiration. No adverse event. MD contacted patient, but she declined revaccination.
Elevated, sustained, pounding resting heart rate for 3 days. About 20-30 beats per minute faster than normal resting heart rate that could not be lowered by breathing or relaxation exercises. Very uncomfortable feeling on upper body, head and behind eyes with the heart rate.
Pt recvd vax 30JUN92 & on 1JUL92 devel h/a that progressed to nausea, vomiting, numbness around the mouth, tingling sensation in feet, hands & both arms & felt cold & clammy; BP 130/70; sx were described as being very similar to migraine;
while administering a Fluzone HD injection to a 72 years old female patient it started to leak between the plastic collar and syringe/No AE; while administering a Fluzone HD injection to a 72 years old female patient it started to leak between the plastic collar and syringe, the vaccine was dripped in her arm/No AE; while administering a Fluzone HD injection to a 72 years old female patient it started to leak between the plastic collar and syringe/No AE; Initial information received on 24-Oct-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 72 years old female patient who had vaccine underdose (underdose) and exposure via skin contact (exposure via skin contact), while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ292AB, expiry date: 10-JUN-2020, dose: 0.5 ml via intramuscular route in the left arm on 24-Oct-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of vaccine underdose and exposure via skin contact.  It was also a case of syringe leak.   It was reported that while administering a Fluzone High-Dose injection to a 72 years old female patient it started to leak between the plastic collar and syringe, the vaccine was dripped in her arm.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
The next day after getting the vaccine I began to experience pain in my heart. After a while the pain went away and it came back recently and now it is intense.
03/15/2021: Presented to the emergency department for chest pain. Patient was admitted for observation and discharged the following day. The chest pain had resolved and multiple troponins were negative.
Systemic: Fainting / Unresponsive-Mild, Additional Details: pt fainted 5 min after shot, no loc, per pt, did not drink or eat much in the am, pt given food and water, observed for 30 min with no other issues, will reach out to pt to check up later in day
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX vaccine to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In May 2012, a healthcare provider at a health department administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On an unknown date in 2015, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
I noticed some bruising and contacted my doctor, and they ran some blood work and that is when they noticed my platelets were low. My platelets dropped again and had to be hospitalized for one night and given steroids and platelets. I was taking Tamoxifen at the time, and I stopped, and it seemed to be related to that. My platelets are stabilized at this time.
within 4 hours of receiving the vaccine I had nausea, headache, & extreme body aches. the vaccine also caused my period to be a week late (I have never had a late period in my adult life)